Skip to main content

Table 1 Demographic features of the study patients

From: Modulations of cell cycle checkpoints during HCV associated disease

 

Mean Age (years)

Gender (male/female)

Virus infection

*Stage of Fibrosis

*Grade of Inflammation

a) Patients included in PCR array experiments

Early HCV

(n = 4)

40 ± 6.2

2/2

HCV

0–1

0–1

Advanced

HCV

(n = 4)

53 ± 4.9

2/2

HCV

3–4

3–4

b) Patients included in Immunohistochemistry experiments

Chronic HCV

(n = 38)

42+9.3

18/20

HCV

0–4

1–4

Non-viral hepatitis (n = 6)

49 ± 2.1

2/4

None

1–4

1–3

Normal

(n = 4)

26 ± 4.0

2/2

None

-

-

  1. * Histopathological staging and grading of tissue samples were performed according to Batts Ludwig scoring system.